Delivery Order SPE2DB22D3301-SPE2DB24FY2MN

Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the supply of 4,563,589,780 units of the prescription medication Alfuzosin HCl ER 10 mg tablets. The $1,001.74 delivery order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The contract has a ceiling value of $1,677.32 and is a firm-fixed-price contract type. The ultimate completion date for this order is September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,325,624 units of the prescription medication Alfuzosin HCl ER 10 mg Tablet. The $2,421.58 firm fixed price contract has a period of performance through April 19, 2024 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order valued at $2,506.72 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 120 tablets of Alfuzosin HCl ER 10 mg. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in effect through December 2025. The contract does not have a set-aside designation and is intended to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,863,575 units of Alfuzosin HCL ER 10 mg tablets, with a ceiling value of $16,832.49. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing structure. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,881.57, is for the supply of Alfuzosin HCl ER 10 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $1,878.00, is for the supply of 120 tablets of the prescription medication Alfuzosin Hydrochloride Extended Release 10 mg. The contract has a firm fixed price and runs until July 25, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various government...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,024.84 firm fixed price delivery order is for the supply of 10 mg alfuzosin hydrochloride extended-release tablets. Amerisourcebergen Drug Corp holds a larger, single-award indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $9,984.53, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. This is a firm fixed-price delivery order contract with an ultimate completion date of November 18, 2024. The contract is not designated with a set-aside requirement, indicating open...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY2MN
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count tablets of Alfuzosin Hydrochloride Extended Release 10 milligram. The contract has a ceiling value of $2,202.21 and a period of performance through March 14, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation.

Generated 6/12/24, 9:54 AM